The effects of ranibizumab on surgically induced endometriosis in a rat model: A preliminary study


ŞEVKET O., Sevket A., BÜYÜKPINARBAŞILI N., Molla T., KILIÇ G., ATEŞ S., ...Daha Fazla

Reproductive Sciences, cilt.20, sa.10, ss.1224-1229, 2013 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 10
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1177/1933719113483012
  • Dergi Adı: Reproductive Sciences
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1224-1229
  • Anahtar Kelimeler: endometriosis, ranibizumab, VEGF
  • Sağlık Bilimleri Üniversitesi Adresli: Hayır

Özet

Objective: To examine the effect of ranibizumab on surgically induced endometriosis in rat models. Study Design: Endometrial tissue was implanted onto the abdominal peritoneum of 20 rats that were randomized into 2 groups. The rats in group 1 (n = 9) were given 0.6 mg/kg ranibizumab on the 1st and 14th days after the second operation. The rats in group 2 (control group, n = 9) received no medication. All the rats were observed for a total of 28 days. Results: At the end of the treatment, the mean volume and weight of the explants in group 1 (11.49±6.87 mm3 and 36.61±17.84 mg) were significantly lower than that of the control group (190.6 ± 177.4 mm3 and 187.3 ± 174.5 mg; both Ps < .01). Mean epithelial histologic scores were significantly lower in group 1 (1.11 ± 0.78) than that of the control group (2.33 ± 0.71; P < .01). When compared with the control group, vascular endothelial growth factor (VEGF) immunoreactivities in group 1 showed statistically significant reductions (1.67 ± 0.50; 2.67 ± 0.50; P < .01). Conclusion: Ranibizumab has significantly regressed the size of the endometriotic implants and caused atrophy of these lesions in rats by decreasing explant levels of VEGF. © The Author(s) 2013.